EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification and characterization of calreticulin as a novel plasminogen receptor

Alamelu G Bharadwaj, Gillian C Okura, John W Woods, Erica A Allen, Victoria A Miller, Emma Kempster, Mark A Hancock, Shashi Gujar, Rimantas Slibinskas, David M Waisman

Journal of Biological Chemistry · 2024

DOI: 10.1016/j.jbc.2023.105465 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Alamelu G Bharadwaj und 9 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada; Biochemistry and Molecular Biology, Dalhousie University, Halifax, Nova…. Hauptthemen laut MEDLINE: Calreticulin, Plasminogen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Cancer Society, Canada Foundation for Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Calreticulin (CRT) was originally identified as a key calcium-binding protein of the endoplasmic reticulum. Subsequently, CRT was shown to possess multiple intracellular functions, including roles in calcium homeostasis and protein folding. Recently, several extracellular functions have been identified for CRT, including roles in cancer cell invasion and phagocytosis of apoptotic and cancer cells by macrophages. In the current report, we uncover a novel function for extracellular CRT and report that CRT functions as a plasminogen-binding receptor that regulates the conversion of plasminogen to plasmin. We show that human recombinant or bovine tissue-derived CRT dramatically stimulated the conversion of plasminogen to plasmin by tissue plasminogen activator or urokinase-type plasminogen activator. Surface plasmon resonance analysis revealed that CRT-bound plasminogen (KD = 1.8 μM) with moderate affinity. Plasminogen binding and activation by CRT were inhibited by ε-aminocaproic acid, suggesting that an internal lysine residue of CRT interacts with plasminogen. We subsequently show that clinically relevant CRT variants (lacking four or eight lysines in carboxyl-terminal region) exhibited decreased plasminogen activation. Furthermore, CRT-deficient fibroblasts generated 90% less plasmin and CRT-depleted MDA MB 231 cells also demonstrated a significant reduction in plasmin generation. Moreover, treatment of fibroblasts with mitoxantrone dramatically stimulated plasmin generation by WT but not CRT-deficient fibroblasts. Our results suggest that CRT is an important cellular plasminogen regulatory protein. Given that CRT can empower cells with plasmin proteolytic activity, this discovery may provide new mechanistic insight into the established role of CRT in cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CalreticulinPlasminogenAnimalsCattleHumansFibrinolysinTissue Plasminogen ActivatorUrokinase-Type Plasminogen ActivatorProtein DomainsMutationRecombinant ProteinsGene Knockout TechniquesCell Line, TumorNeoplasms

Stichwörter der Autor:innen

calreticulinplasminplasminogenplasminogen regulationtissue plasminogen activator

Substanzen

CalreticulinFibrinolysinPlasminogenTissue Plasminogen ActivatorUrokinase-Type Plasminogen ActivatorRecombinant Proteins

Autor:innen und Institutionen

  • Departments of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada; Biochemistry and Molecular Biology, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Departments of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Biochemistry and Molecular Biology, Dalhousie University, Halifax, Nova Scotia, Canada.
  • McGill SPR-MS Facility, McGill University, Montréal, Québec, Canada.
  • Life Sciences Center, Institute of Biotechnology, Vilnius University, Vilnius, Lithuania.
  • Departments of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada; Biochemistry and Molecular Biology, Dalhousie University, Halifax, Nova Scotia, Canada. Electronic address: david.waisman@dal.ca.

Förderung

  • Canadian Cancer Society
  • Canada Foundation for Innovation

Zitieren

APA

Bharadwaj, A. G., Okura, G. C., Woods, J. W., Allen, E. A., Miller, V. A., Kempster, E., Hancock, M. A., Gujar, S., Slibinskas, R., & Waisman, D. M. (2024). Identification and characterization of calreticulin as a novel plasminogen receptor. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.105465

Vancouver

Bharadwaj AG, Okura GC, Woods JW, Allen EA, Miller VA, Kempster E, et al. Identification and characterization of calreticulin as a novel plasminogen receptor. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2023.105465

BibTeX
@article{Bharadwaj2024,
  author = {Bharadwaj, Alamelu G and Okura, Gillian C and Woods, John W and Allen, Erica A and Miller, Victoria A and Kempster, Emma and Hancock, Mark A and Gujar, Shashi and Slibinskas, Rimantas and Waisman, David M},
  title = {Identification and characterization of calreticulin as a novel plasminogen receptor},
  journal = {Journal of Biological Chemistry},
  year = {2024},
  doi = {10.1016/j.jbc.2023.105465}
}
Kostenlos starten →